Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ACVU advanced for three days, in 163 of 189 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on ACVU as a result. In 43 of 53 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for ACVU just turned positive on October 06, 2026. Looking at past instances where ACVU's MACD turned positive, the stock continued to rise in 25 of 30 cases over the following month. The odds of a continued upward trend are 83%.
ACVU moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ACVU crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 166 of 215 cases where ACVU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
The 10-day RSI Indicator for ACVU moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 21 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 72%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 28 of 43 cases where ACVU's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 65%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACVU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
ACVU broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The 10-day moving average for JNJ crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 65%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where JNJ's RSI Indicator exited the oversold zone, 17 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 59%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on JNJ as a result. In 39 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 46%.
The Moving Average Convergence Divergence (MACD) for JNJ just turned positive on October 21, 2026. Looking at past instances where JNJ's MACD turned positive, the stock continued to rise in 21 of 47 cases over the following month. The odds of a continued upward trend are 45%.
JNJ moved above its 50-day moving average on October 26, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where JNJ advanced for three days, in 164 of 354 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.
The Aroon Indicator entered an Uptrend today. In 124 of 260 cases where JNJ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 48%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JNJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.
JNJ broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 15 (best 1 - 100 worst), indicating outstanding price growth. JNJ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.834) is normal, around the industry mean (-1.421). P/E Ratio (31.640) is within average values for comparable stocks, (21.700). Projected Growth (PEG Ratio) (2.852) is also within normal values, averaging (5.738). Dividend Yield (0.019) settles around the average of (0.038) among similar stocks. P/S Ratio (6.658) is also within normal values, averaging (4.033).
JNJ | ||
|---|---|---|
OUTLOOK RATING 1..100 | 26 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 2 | |
SMR RATING 1..100 | 37 | |
PRICE GROWTH RATING 1..100 | 15 | |
P/E GROWTH RATING 1..100 | 7 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ACVU | JNJ | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 72% | 6 days ago 59% |
| Stochastic ODDS (%) | 2 days ago 65% | 2 days ago 48% |
| Momentum ODDS (%) | 6 days ago 81% | 2 days ago 46% |
| MACD ODDS (%) | 7 days ago 83% | 2 days ago 45% |
| TrendWeek ODDS (%) | 2 days ago 84% | 2 days ago 47% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 50% |
| Advances ODDS (%) | 2 days ago 86% | 3 days ago 46% |
| Declines ODDS (%) | 6 days ago 66% | 9 days ago 43% |
| BollingerBands ODDS (%) | 2 days ago 76% | 2 days ago 44% |
| Aroon ODDS (%) | 2 days ago 77% | 2 days ago 48% |
A.I.dvisor tells us that ACVU and V have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACVU and V's prices will move in lockstep.
| Ticker / NAME | Correlation To ACVU | 1D Price Change % | ||
|---|---|---|---|---|
| ACVU | 100% | +0.04% | ||
| V - ACVU | 16% Poorly correlated | +0.38% | ||
| JNJ - ACVU | 14% Poorly correlated | -0.47% | ||
| SPG - ACVU | 14% Poorly correlated | +0.63% | ||
| TSN - ACVU | 14% Poorly correlated | +0.70% | ||
| BLK - ACVU | 13% Poorly correlated | +0.61% | ||
More | ||||
A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with GSK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then GSK could also see price increases.
| Ticker / NAME | Correlation To JNJ | 1D Price Change % | ||
|---|---|---|---|---|
| JNJ | 100% | -0.47% | ||
| GSK - JNJ | 53% Loosely correlated | -0.60% | ||
| ABBV - JNJ | 53% Loosely correlated | +0.20% | ||
| NVS - JNJ | 52% Loosely correlated | -0.26% | ||
| MRK - JNJ | 48% Loosely correlated | -0.48% | ||
| AMGN - JNJ | 47% Loosely correlated | N/A | ||
More | ||||